Thursday, June 09, 2016

Effect of the intake of Omega-7 vs. placebo on the components of the lipid profile in patients with Metabolic Syndrome


During this week I finally concluded with my thesis, finding some very interesting results, so I'd like to talk a little about it.

Nowadays a huge number of scientific evidence is proving the benefits obtained on the control of blood lipids and cardiovascular diseases by the consumption Omega-3, but we don't have enough knowledge about the impact that could have other "healthy" fatty acids like Omega-7. 


In the above highlights the importance of analyzing the effect of Omega-7. Therefore we make a double-blind clinical trial, that included 60 patients from the Health Center East Zone in the state of Colima diagnosed with metabolic syndrome. They were randomly divided in two groups and subjected to a treatment protocol with Omega-7 or placebo. The protocol was carried out for a month and the lipid profile was evaluated at the beginning and at the end of the intervention.


Finding at the end of the study than the group that received Omega-7 showed a significant decrease in total cholesterol and c-no-HDL levels and a significant increase in levels of HDL-c. Anthropometric measurements showed a significant decrease in waist and hip in the same group.

Therefore we can consider the Omega-7 as part of the treatment of metabolic syndrome, because it acts on a par of the components of this syndrome.

Wednesday, June 01, 2016

Refresher Course: Nutritional Imbalance in Cancer Patients



On Monday and Tuesday was held at the State Cancer Institute, the first refresher course 'Nutritional Imbalance in Cancer Patients', which was full of very interesting lectures.

The course consisted of various topics, such as:
  • Feeding tubes.
  • Care and handling of the feeding tubes.
  • Chemotherapy toxicity.
  • Nutrition in children with stress.
  • Toxicity of drugs in the pediatric area.
  • Radiation toxicity.
  • Immunonutrition in cancer patients.
  • Oncological surgery and nutritional risk.
  • Assessment of nutritional status in cancer patients.
For me the course was incredible, I liked all the topics, but the one that caught my attention was Immunonutrition.


This conference speaks of the use of various nutrients that can improve the health of patients with cancer and was also motivational for the area of nutrition. These nutrients include:
  • Glutamine: It's the preferred energy substrate for cells with high proliferative capacity, such as intestinal epithelial cells, the immune system, the renal tubule and erythrocytes. Which they're damaged by chemotherapy and radiotherapy.
  • Arginine: It has cytotoxic effects (expels various pathogenic microorganisms), and cytostatic (inhibit the growth of microorganisms). And generates nitric oxide also has tumoricidal function may eliminate tumor cells.
  • Omega 3: It has an anti-inflammatory effect and stimulates the immune system function.
  • Probiotics: They favor the formation of intestinal microbiota and is a trophic stimulation of gastrointestinal mucosa.
The immunonutrients are added to a complete diet, and depending on the patient can be supplied enteral, parenteral or oral.